Lobbying Governance
| Overall Assessment | Analysis | Score |
|---|---|---|
| None |
No evidence found
View Sources
|
E |
Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up| Overall Assessment | Analysis | Score |
|---|---|---|
| None |
No evidence found
View Sources
|
E |
| Overall Assessment | Analysis | Score |
|---|---|---|
| None |
We found no evidence that Recursion Pharmaceuticals discloses any engagement on climate-related public policy. The company’s discussion of lobbying focuses on modernising U.S. Food and Drug Administration processes for AI-enabled drug discovery, which is unrelated to climate policy, and it does not identify any climate laws or regulations, describe mechanisms or targets for climate-policy engagement, or state any desired climate-policy outcomes. As a result, the company provides no transparency regarding climate-related lobbying activities.
|
E |